Literature DB >> 17539689

Application of a 6pi-1-azatriene electrocyclization strategy to the total synthesis of the marine sponge metabolite ageladine A and biological evaluation of synthetic analogues.

Matthew L Meketa1, Steven M Weinreb, Yoichi Nakao, Nobuhiro Fusetani.   

Abstract

A 12-step synthesis of the angiogenesis inhibitory marine metabolite ageladine A is reported. The key steps include a 6pi-1-azatriene electrocyclization for formation of the pyridine ring and a Suzuki-Miyaura coupling of N-Boc-pyrrole-2-boronic acid with a chloroimidazopyridine. In addition, an assessment of the biological activity of a variety of synthetic analogues of ageladine A prepared during this synthesis is described.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539689     DOI: 10.1021/jo0707232

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  5 in total

1.  Synthesis and anticancer activities of ageladine A and structural analogs.

Authors:  Yuelong Ma; Sangkil Nam; Richard Jove; Kenichi Yakushijin; David A Horne
Journal:  Bioorg Med Chem Lett       Date:  2009-11-14       Impact factor: 2.823

2.  Intramolecular azavinyl carbene-triggered rearrangement of furans.

Authors:  Anton S Makarov; Maxim G Uchuskin; A Stephen K Hashmi
Journal:  Chem Sci       Date:  2019-07-26       Impact factor: 9.825

Review 3.  A submarine journey: the pyrrole-imidazole alkaloids.

Authors:  Barbara Forte; Beatrice Malgesini; Claudia Piutti; Francesca Quartieri; Alessandra Scolaro; Gianluca Papeo
Journal:  Mar Drugs       Date:  2009-11-27       Impact factor: 5.118

Review 4.  Marine-derived angiogenesis inhibitors for cancer therapy.

Authors:  Ying-Qing Wang; Ze-Hong Miao
Journal:  Mar Drugs       Date:  2013-03-15       Impact factor: 5.118

5.  Reporter dyes demonstrate functional expression of multidrug resistance proteins in the marine flatworm Macrostomum lignano: the sponge-derived dye Ageladine A is not a substrate of these transporters.

Authors:  Kristin Tietje; Georgina Rivera-Ingraham; Charlotte Petters; Doris Abele; Ralf Dringen; Ulf Bickmeyer
Journal:  Mar Drugs       Date:  2013-10-16       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.